Status:
TERMINATED
Thromboprophylaxis in Critically Ill Patients
Lead Sponsor:
Medical University of Vienna
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
Intensive care patients are at high risk to develop deep venous thrombosis and pulmonary embolism. Despite anticoagulation with heparin 7% of ICU patients suffer from this serious complication. Optima...
Detailed Description
Background: The optimal dose regimen of low molecular weight heparins (LMWH) for thromboprophylaxis in critically ill patients is unknown. Objectives: We performed a prospective, randomized study to ...
Eligibility Criteria
Inclusion
- Requirement for prophylactic anticoagulation, patient age ³19 years, creatinine clearance within normal range, prothrombin time \>30% and thrombocyte counts \>100 G/l.
Exclusion
- Estimated time of admission less than 24 hours, full anticoagulation, renal failure, history of heparin-induced thrombocytopenia, hereditary or acquired coagulation disorders.
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
April 1 2005
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00437697
Start Date
April 1 2003
End Date
April 1 2005
Last Update
February 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Vienna, Austria, 1090